Compound coenzyme for injection

This product is a complex of various coenzymes and bioactive substances extracted and refined from fresh edible yeast. Among them, coenzyme A, coenzyme I, reduced glutathione and other components are mostly coenzymes of important enzymes in acetylation reactions, redox reactions, transmethylation reactions and energy metabolism in the human body. They play an important role in the metabolism of sugar, protein, fat and energy in the body, and are closely related to glycolysis, tricarboxylic acid cycle, fatty acid β-oxidation, glycogen synthesis and decomposition, acetylcholine synthesis, tissue respiration, energy transfer, liver protection and detoxification, and anti-radiation (radiation) effects. Since most biochemical reactions in cells are continuous multi-step reactions or chain reaction rings, the completion of the reaction requires the participation of multiple coenzymes and related active substances. Therefore, the simultaneous presence of these coenzymes can complement each other.

This product is a compound preparation, whose components include 100 units of coenzyme A, 10.1 mg of coenzyme, 1 mg of reduced glutathione, adenosine triphosphate, nucleotides and other biologically active substances.

This product is a white or light yellow freeze-dried block, which should be a light yellow clear liquid after dissolution.

It is used for acute and chronic hepatitis, idiopathic thrombocytopenic purpura, and leukocytopenia and platelet decrease caused by chemotherapy and radiotherapy; it has a certain auxiliary therapeutic effect on coronary artery sclerosis, chronic arteritis, myocardial infarction, oliguria and uremia caused by renal insufficiency.

Intramuscular injection: 1-2 vials each time, dissolve in 1-2ml 0.9% sodium chloride injection and inject intramuscularly. Intravenous drip: 1-2 vials each time, dilute in 5% glucose injection and drip intravenously. 1-2 times a day or once every other day. For patients with severe wasting diseases and tumors, increase the dosage as appropriate according to the doctor's advice.

1 Gastrointestinal reactions: May cause digestive dysfunction, such as upper abdominal pain, nausea, and diarrhea. The drug is rarely discontinued due to this. Taking the drug after meals can reduce or avoid side effects of the digestive system. 2 Rash: Generally papular erythema, eczema, or prurigo. If the rash is extensive and persistent, and symptomatic treatment is ineffective and there is a tendency to worsen, the drug must be discontinued. 3 Rarely, there may be leukopenia, thrombocytopenia, anemia, and bone marrow suppression, which mainly occur in patients with renal insufficiency. If such adverse reactions occur, drug discontinuation should be considered. 4 Others include hair loss, fever, lymphadenopathy, hepatotoxicity, interstitial nephritis, and allergic vasculitis. The above adverse reactions generally occur after discontinuation of the drug.

1. Patients who are allergic to this product are prohibited from using it. 2. Pregnant women are prohibited from using it. 3. Patients in the early stage of cerebral hemorrhage are prohibited from using it. 4. Patients with atrioventricular block are prohibited from using it.

Precautions during pregnancy and lactation: Contraindicated for use during pregnancy.

Not yet clear

Sealed, store in a cool dark place (avoid light and not exceed 20℃). 24 months

Coenzyme A 200 units, coenzyme I 0.2 mg

24 months

Beijing SL Pharmaceutical Co., Ltd.

• Founded in:

  1994-12-24

• Address:

  4th Floor, Building 1, Bitongyuan, No. 69, Fushi Road, Haidian District, Beijing

• Tax NO.:

  91110000102299779W

• Registered Funds:

  1,027.35 million yuan

• Website:

  Log in to view

• Email:

  Log in to view